Vivanza Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 530057 | NSE: | Trading | Small Cap

Vivanza Biosciences Share Price

2.62 -0.05 -1.87%
as on 25-Feb'25 16:59

DeciZen - make an informed investing decision on Vivanza Biosciences

M-Cap below 100cr DeciZen not available

Vivanza Biosciences stock performance -

P/E Ratio (SA):
0.00
Market Cap:
10.7 Cr.
52-wk low:
2
52-wk high:
9.5

Is Vivanza Biosciences Ltd an attractive stock to invest in?

1. Is Vivanza Biosciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vivanza Biosciences Ltd is a below average quality company.

2. Is Vivanza Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Vivanza Biosciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Vivanza Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vivanza Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vivanza Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vivanza Biosciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -9%-10.6%-4.9%14.3%-0.6%6.1%17.8%15.2%11.7%9%-
Value Creation
Index
-1.6-1.8-1.40.0-1.1-0.60.30.1-0.2-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 003.56.42.29.49.29.214.214.45
Sales YoY Gr.-NANA85.6%-65.5%322.1%-1.6%-0.8%55.3%1.4%-
Adj EPS -0-0.3-00.1-0.1-0.100.10.20.1-0
YoY Gr.-NANANA-283.3%NANA366.7%7.1%-46.7%-
BVPS (₹) 00.10.910.90.80.811.11.21.3
Adj Net
Profit
-0.1-0.1-0.20.2-0.5-0.20.10.50.60.30
Cash Flow from Ops. 0-0.1-2-0.21.42.8-3.1-0.70.21.8-
Debt/CF from Ops. -10.7-10.9-0.3-4.70.70.1-0.1-6.540.81.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA45.4%16.1%1.4%
Adj EPS NANA38.7%-46.7%
BVPS50.4%6.3%12%7.3%
Share Price 17.3% 14.9% -44.5% -66.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-27.3-63.2-9.36.3-12.2-6.131514.37-2.5
Op. Profit
Mgn %
00-4.69.9-1.3-3.21.425.45.67.9
Net Profit
Mgn %
00-53.7-20.2-2.21.15.94.12.2-2.4
Debt to
Equity
3.820.30.10.20.30.10.11.21.50.7-
Working Cap
Days
004185131,865486441427394421359
Cash Conv.
Cycle
0013711496-16131609610374

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 16.05%

Debt to equity has declined versus last 3 years average to 0.69

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -72.40%

Latest Financials - Vivanza Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) -0 -0
TTM Sales (₹ Cr.) 5.1 11.4
BVPS (₹.) 1.3 1.2
Reserves (₹ Cr.) 1 1
P/BV 2.14 2.15
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 2.00 / 9.54
All Time Low / High (₹) 0.05 / 21.00
Market Cap (₹ Cr.) 10.7
Equity (₹ Cr.) 4
Face Value (₹) 1
Industry PE 53.4

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 19.8 -2.817.6 2.521 6.317 -14.9
Adj EPS (₹) 5.7 322.28.9 21.28.1 64.2-2.7 -132.6
Op. Profit Mgn % 8.04 -337 bps5.89 -221 bps9.82 93 bps4.25 -731 bps
Net Profit Mgn % 26.44 2034 bps46.40 714 bps35.21 1237 bps-14.71 -5311 bps

Management X-Ray of Vivanza Biosciences:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:20.02%Institutions:0%Non-Institutions:79.98%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%10%20%30%40%50%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vivanza Biosciences

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Vivanza Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Redington 249.4 -1.2 (-0.5%) Small Cap 41,228 17.8 2.6 14.1 4.5
Amrapali Industries 16.1 0.1 (0.5%) Small Cap 27,301 0.1 0 125.6 2.6
Rashi Peripheral 281 -2.3 (-0.8%) Small Cap 10,731 28.3 1.3 10 1.1
Prithvi Exchange (I) 160.5 3.2 (2%) Small Cap 4,160 13.7 0.3 11.5 2.6
Remedium Lifecare 2.9 -0.2 (-4.9%) Small Cap 4,042 -1.2 0.4 - 2.7
SG Mart 344.2 5.5 (1.6%) Small Cap 2,683 9.4 2.2 36.1 3.3
Manoj Vaibhav Gems 215.3 -1.1 (-0.5%) Small Cap 2,150 19.3 3.8 11.2 1.5
Sakuma Exports 2.9 -0 (-1%) Small Cap 1,874 0.1 0.5 35.1 0.9
Honasa Consumer 221.8 -1.6 (-0.7%) Small Cap 1,764 2.1 6.4 106.5 6.2
Anmol India 17.5 -1 (-5.4%) Small Cap 1,501 1.6 1.3 11.3 1
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales003.476.442.229.379.229.1514.2114.41
Operating Expenses 0.050.063.645.802.259.669.099.0713.4713.61
Manufacturing Costs000.020.0900.040.010.1000.03
Material Costs003.075.531.989.148.568.4812.9612.98
Employee Cost 000.260.060.020.100.110.080.220.31
Other Costs 0.050.060.280.130.250.390.410.410.290.28
Operating Profit -0.05-0.06-0.160.64-0.03-0.300.130.070.740.81
Operating Profit Margin (%) ---4.6%9.9%-1.3%-3.2%1.4%0.8%5.2%5.6%
Other Income 000.05000.530.500.830.390.05
Interest 000.040.370.420.440.470.430.430.42
Depreciation 0000000.010.0100.01
Exceptional Items 0000000000
Profit Before Tax -0.05-0.06-0.160.27-0.45-0.200.150.460.690.43
Tax 0000.03000.0500.120.11
Profit After Tax -0.05-0.06-0.160.24-0.45-0.200.100.460.570.32
PAT Margin (%) ---4.6%3.7%-20.2%-2.2%1.1%5.1%4.0%2.2%
Adjusted EPS (₹)0.0-0.30.00.1-0.1-0.10.00.10.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.170.023.683.923.473.273.373.834.404.72
Share Capital 3.760.1944444444
Reserves -3.59-0.16-0.32-0.08-0.53-0.73-0.63-0.170.400.72
Minority Interest0000000000
Debt0.480.500.530.770.900.180.184.426.563.26
Long Term Debt0000000000.78
Short Term Debt0.480.500.530.770.900.180.184.426.562.49
Trade Payables0.050.052.564.845.758.143.865.488.668.23
Others Liabilities 0.050.060.160.140.710.690.530.470.820.66
Total Liabilities 0.740.646.939.6610.8312.287.9314.2120.4416.87

Fixed Assets

Gross Block0000000.020.020.020.06
Accumulated Depreciation0000000.010.020.020.03
Net Fixed Assets0000000.01000.03
CWIP 0000000000
Investments 001.911.911.911.911.911.911.911.91
Inventories001.812.281.910.850.402.231.611.80
Trade Receivables002.535.075.546.416.117.3512.1810.37
Cash Equivalents 0.050.03-2.33-3.02-3.03-2.81-3.110.020.100.09
Others Assets0.680.603.013.414.505.922.612.694.622.67
Total Assets 0.740.646.939.6610.8312.287.9314.2120.4416.87

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.04-0.05-1.98-0.161.372.80-3.08-0.680.161.80
PBT -0.05-0.06-0.160.27-0.45-0.200.150.460.690.43
Adjustment 000.070.360.430.440.480.410.420.43
Changes in Working Capital 0.010.01-1.9-0.791.392.56-3.65-1.55-0.831.05
Tax Paid 000000-0.050-0.12-0.11
Cash Flow From Investing Activity 001.90000-0.0200-0.04
Capex 000000-0.0200-0.04
Net Investments 001.900000000
Others 0000000000
Cash Flow From Financing Activity 0.090.02-2.28-0.53-1.38-2.582.800.65-0.08-1.77
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 00-0.04-0.36-0.42-0.44-0.47-0.41-0.42-0.41
Dividend Paid 0000000000
Others 0.090.02-2.24-0.17-0.96-2.143.271.060.34-1.36
Net Cash Flow 0.05-0.02-2.36-0.69-0.010.22-0.30-0.030.09-0.01
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-34.4-79.68-8.586.32-12.16-6.053.0112.8913.846.97
ROCE (%)-8.96-10.61-4.8814.33-0.636.0717.8315.1911.668.96
Asset Turnover Ratio000.920.780.220.820.910.830.820.77
PAT to CFO Conversion(x)N/AN/AN/A-0.67N/AN/A-30.8-1.480.285.63
Working Capital Days
Receivable Days00266215872231248269251286
Inventory Days001901163445425524943
Payable Days00155244973277256201199237

Vivanza Biosciences Ltd Stock News

Vivanza Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vivanza Biosciences on 25-Feb-2025 16:59 is ₹2.62.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 25-Feb-2025 16:59 the market cap of Vivanza Biosciences stood at ₹10.68.
The latest P/E ratio of Vivanza Biosciences as of 25-Feb-2025 16:59 is 0.00.
The latest P/B ratio of Vivanza Biosciences as of 25-Feb-2025 16:59 is 2.14.
The 52-week high of Vivanza Biosciences is ₹9.54 and the 52-week low is ₹2.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivanza Biosciences is ₹5.07 ( Cr.) .

About Vivanza Biosciences Ltd

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business area of the company

The company is engaged in the business of business of Pharmaceutical Products.

Products

  • Gloves
  • Surgicals
Read More Read Less
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on